Search filters

List of works by Sweilem B Al Rihani

ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System

scientific article published on 03 July 2020

Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation study

scientific article published on 25 August 2021

Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition

journal article from 'Pharmaceutics' published in 2021

Crocetin promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway

scientific article published on 06 January 2021

Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

journal article from 'International Journal of Molecular Sciences' published in 2021

Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice

scientific article published on 04 September 2020

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models

publication published on 09 November 2021

Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs

scientific article published on 05 September 2020

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy

scientific article published on 10 August 2020

Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: a systematic review

scientific article published on 25 April 2020